Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
In an early clinical research, 138 patients completed the treatment of Psoriasis Vulgaris by
Acitretin Capsules in 8 weeks, the results indicate 75 cases effectively (54.3%), 50 cases
invalid(36.2%), 13 cases serious(9.4%). To investigate the influence of genetic factors on
the curative effect and find the relationships between genetic variants and the response of
Acitretin Capsules to treatment of Psoriasis Vulgaris.